The emergence of immune checkpoint inhibitors has dramatically changed the therapeutic landscape for patients with advanced melanoma. However, relatively low response rates and a high incidence of sev
Additional file 3: Figure S2. Multiomics data analysis of CNV, histones marks, and transcriptomic gene expression data for the indicated exclusively expressed proteins in dormant or parental cells fro
